Philip Morris
Regulatory Decision - Making Under Uncertainty: the Case of Alar
Fields
- Type
- REPT, REPORT, OTHER
- CHAR, CHART, GRAPH, TABLE, MAPS
- Area
- LOGUE,MAYADA/OFFICE
- Site
- N426
- Characteristic
- EXTR, EXTRA
- Document File
- 2025545619/2025546382/Harvard University Office of
- Continuing Education Short Course Program Harvard School
- of Public Health
- Continuing Education Short Course Program Harvard School
- Master ID
- 2025545673/6381
Related Documents:- 2025545673-6381 Risk Analysis in Occupational and Environmental Health 910904 - 910906
- 2025545684 Telephone Locations and Protocol
- 2025545689-5696 Risk Assessment for Carcinogens: A Comparison of Approaches of the Acgih and the Epa
- 2025545697 Hps Newsletter Interview with A Risk Expert
- 2025545698-5711 Science and Its Limits: the Regulator's Dilemma
- 2025545713-5721 Risk / Benefit Analysis
- 2025545722-5725 Risk Management Commentary for Dr. D. Allan Bromley Assistant to the President for Science and Technology
- 2025545726-5729 Risk Assessment and Comparisons: An Introduction
- 2025545750-5792 Risk Assessment of Chemical Carcinogens: Is It Time for A Change?
- 2025545795-5799 Tools of Risk Analysis Applications of Epidemiology
- 2025545800-5810 Notice of Intended Changes - Benzene
- 2025545811-5822 Epidemiology in Risk Assessment for Regulatory Policy
- 2025545824-5850 Risk Analysis in Environmental and Occupational Health Use of Animal and Other Data As Predictors of Human Risk
- 2025545851-5871 Risk Analysis in Environmental and Occupational Health Uncertainties in Predicting Human Risks
- 2025545872-5881 How Do Cancer Risks Predicted From Animal Bioassays Compare with the Epidemiologic Evidence? the Case of Ethylene Dibromide
- 2025545882-5887 Use of Biological Assays in Short-Term Assessment of Inhaled Substances
- 2025545888
- 2025545889-5891 Risk Analysis in Environmental and Occupational Health Are Your Mushrooms Safe to Eat?
- 2025545892-5899 the Rat As An Experimental Animal
- 2025545901-5907 Non-Cancer Endpoints
- 2025545910-5939 Cancer Facts & Figures - 890000
- 2025545940-5941 Cancer Facts & Figures - 890000
- 2025545942-5944 Get - the - Lead - Out Guru Challenged A Decade-Old Scientific Argument Over the Effects of Low-Level Lead on Iq Turns Nasty Following Allegations of Misconduct
- 2025545945-5948
- 2025545949-5958 the Question of Thresholds for Radiation and Chemical Carcinogenesis
- 2025545959-5980 Are There Thresholds for Carcinogenesis? the Thorny Problem of Low-Level Exposure
- 2025545981-5990 Perspectives on Comparing Risks of Environmental Carcinogens
- 2025545991-5998 Acceptable Cancer Risks: Probabilities and Beyond
- 2025546000-6011 Ideas in Pathology Pivotal Role of Increased Cell Proliferation in Human Carcinogenesis
- 2025546012-6017 Cell Proliferation in Carcinogenesis
- 2025546019-6027 the Role of Expert Judgement in Risk Analysis
- 2025546029-6039 the Respiratory Tract As A Route of Exposure
- 2025546040-6045 the Respiratory Tract As A Portal of Entry for Toxic Particles
- 2025546047-6062 Limitations to the Use of Employee Exposure Data on Air Contaminants in Epidemiologic Studies
- 2025546063-6083 Benefit - Cost Analysis of Environmental Regulation: Case Studies of Hazardous Air Pollutants
- 2025546086-6089 Legislative and Regulatory Aspects of Risk
- 2025546090-6099 Connecticut's Dioxin Ambient Air Quality Standard
- 2025546100-6103
- 2025546105 Annals of Radiation Calamity on Meadow Street
- 2025546106 Caution Urged When Using Insect Repellents
- 2025546116 Volatile Organics and Inorganics Action Levels 900400
- 2025546134-6135 Summary of Radon Test Results of the Household Testing Program
- 2025546141-6145 Introduction to Discussion Sessions
- 2025546146-6149 Risk Assessment in Environmental and Occupational Health Risk of Alar (Daminozide)
- 2025546150-6160 Intolerable Risk: Pesticides in Our Children's Food
- 2025546161-6162 Pesticides, Risk, and Applesauce
- 2025546163-6168 Daminozide Special Review Technical Support Document - Preliminary Determination to Cancel the Food Uses of Daminozide
- 2025546169 Daminozide / Udmh
- 2025546170-6172 the Relative Risk of Daminozide (Alar / Kylar) Use
- 2025546173 Be Most Wary of Nature's Own Pesticides
- 2025546174-6175 A Movie Star Pares the Apple Industry
- 2025546176-6183 Summary of Toxicology Data on Daminozide and Udmh
- 2025546184-6194 Attachment I Graphs of Data From NCI / Ntp 83 Daminozide
- 2025546195-6196
- 2025546197-6202 Daminozide Special Review Technical Support Document - Preliminary Determination to Cancel the Food Uses of Daminozide
- 2025546226 Epa Moves to Reassess the Risk of Dioxin Urged on by the Scientific Community, Epa Is Developing A New Model for Estimating Dioxin's Risk
- 2025546227 US Government Orders New Look at Dioxin the Environmental Protection Agency Is Evaluating Data From the Past Decade That Suggest Dioxin's Toxicity May Be Overestimated. A Risk Assessment Model Based on Biological Mechanism Is Being Drawn Up.
- 2025546228-6235 Dioxin Toxicity: New Studies Prompt Debate, Regulatory Action New Data on Dioxin's Effect on Humans, A Clearer Picture of the Cellular Events It Precipitates, and New Animal Toxicity Studies May Provide Epa with A Firm Basis for Regulation
- 2025546236-6250 the Regulation of Gene Expression by 2,3,7, 8-Tetrachlorodibenzo-P-Dioxin
- 2025546251-6253 Dioxin Risks Revisited Armed with A New Understanding of How Dioxin Works on the Molecular Level, A Number of Scientists Are Challenging Epa to Change the Way It Does Risk Assessment
- 2025546255-6258 Lead Toxicity Case Study for Short Course on Risk Analysis in Occupational and Environmental Health 910904 - 910906
- 2025546259-6267 Lead
- 2025546268-6275 Lead in Bone: Implications for Toxicology During Pregnancy and Lactation
- 2025546276-6281 the Long-Term Effects of Exposure to Low Doses of Lead in Childhood An 11 - Year Follow-Up Report
- 2025546282-6285
- 2025546298-6321 Review 890000 Alice Hamilton Lecture Lead and Human Health:Background and Recent Findings
- 2025546323-6348 Traps and Errors in Risk Analysis
- 2025546349-6356 Health Risks the Perception of Reality and the Realty of Perception
- 2025546357-6362 Communicating Risk Under Title III of Sara: Strategies for Explaining Very Small Risks in A Community Context
- 2025546363-6368 Industrial Risk Perceptions
- 2025546369-6370 Too Many Rodent Carcinogens: Mitogenesis Increases Mutagenesis
- 2025546371-6373 Has Risk Assessment Become Too 'conservative'?
- 2025546374-6378 Health and Safety Risk Analyses: Information for Better Decisions
- 2025546379-6381 Telling Reporters About Risk Dealing with Reporters Needn't Be the Least Agreeable Part of the Job.
- Litigation
- Stmn/Produced
- Named Person
- Bradley, E.
- Bush
- Delaney
- Graham, J.D.
- Haun
- Moore, J.
- Moses, S.
- Toth
- Bush
- Request
- Stmn/R1-072
- Named Organization
- 60 Minutes
- Congress
- Epa, Environmental Protection Agency
- Harvard
- Natural Resources Defense Council
- NCI, Natl Cancer Inst
- Public Citizen
- Scientific Advisory Panel
- Uniroyal Chemical
- Usda, U.S. Dept of Agriculture
- Congress
- Date Loaded
- 24 May 1999
- UCSF Legacy ID
- vlp02a00
Document Images
REGULATORY DECISION-MAKING UNDER UNCERTAINTY:
THE CASE OF ALAR*
* This is a teaching case commissioned by the Harvard Center for
Risk Analysis for use by the Office of Continuing Education,
Harvard School of Public Health, for a course on Risk Analysis in
Envirozunental & occupational Health, September 5-7, 1990. The case
was written by Ms. Susan Moses under the supervision of Dr. John
D. Graham.

As Jack Moore, Acting Administrator of the U.S. Environmental
Protection Agency (EPA), hung up the phone, he wondered whether he
should agree to an interview with Ed Bradley for a 60 Minutes
segment on;pesticides.
It was January 1989, George Bush had just been inaugurated
as President, and the Administration had not put forth its policies
on environmental issues. Jack Moore was Acting Administrator of
EPA. He had most recently held the position of Assistant
Administrator for Pesticides and Toxic Substances at EPA. As an
advocate for the use of sound science in the regulatory decision-
making process, he had good working relationships with both
industry and environmentalists alike. Twice before Dr. Moore had
been asked to appear on 60 Minutes (prior to being in the position
of Acting Administrator), and both times he declined. He was under
no pressure from The White House; it was his decision whether to
grant 'L-he interview or not. Not too long ago, Dr. Moore had
received an informal copy of a not-yet-released report on
pesticides in children's food, written by the Natural Resources
Defense Council (NRDC), an advocacy group. He now began to wonder
whether or not there might be some connection between this report
and the:scheduled 60 Minutes segment, particularly since Ed Bradley
had referred to the pesticide Alar, a registered trademark for the
chemical daminozide that is sprayed on apples. Alar, and its
metabol ite unsymmetrical dimethylhydrazine (UDMH), were highlighted
in the NRDC report as potential hazards.
2

Knowing that 60 Minutes is watched by millions of viewers,
Jack Moore began to evaluate the implications of his appearance on
the show and wondered how he should prepare himself if he agreed
to the interview with Ed Bradley.
THE F7PMERAL INSECTICIDE, FUNGICIDE, AND RODENTICIDE ACT (FIFRA)
The Federal Insecticide, Fungicide, and Rodenticide Act
(FIFRik), enacted in 1947, is the federal law regulating pesticide
producats and their use in the United States. Until 1972, the law
focused on the proper labeling of pesticide products. In 1972,
amendrncants Were passed changing FIFRA from a labeling law to a more
comprehensive statute that charged EPA with the responsibility of
premarket data review and registration. These changes reflected
public: concern about potential adverse health effects and the need
to evaluate the "reasonableness°t of any of these risks. Since 1972
there have been a series of FIFRA amendments, and the debate over
the adequacy of the current law in protecting human health and the
environment;continues today.
F]:FRA is a "risk-balancing" statute. EPA weighs any potential
adverse effects of the product against its benefits as part of the
decision-making process. The operating words of the statute are
that the pesticide, when used as directed, "will not cause any
unreasonable risk to man or the environment, taking into account
the economic, social, and environmental costs and benefits of the
use of' the pesticide." This risk/benefit mandate is in contrast
3

to other laws, such as the Delaney Clause of the Federal Food,
Drug, and Cosmetic Act, which bans the use of any intentional food
additive that is shown to be a carcinogen in humans or animals,
regardless of any benefits.
All pesticide products must be registered by EPA prior to
being marketed and distributed in commerce. Manufacturers must
submit toxicological and environmental data to the Agency as part
of their application for product registration. EPA reviews these
data for short-term and long-term toxicity, mutagenicity,
oncogenicity, fetotoxicity, teratogenicity, for effects on wildlife
and other organisms, and for environmental fate and residues in
food or feed.
'Under the Federal Food, Drug, and Cosmetic Act, EPA sets
tolerances for pesticide residues in food. A tolerance is the
maximu,m level of residue permitted in the raw harvested commodity
and on processed forms of the commodity.
If EPA approves a pesticide registration application, the
product may be manufactured for.commerce. However, each product
is approved to control specific pests, for use on specific crops,
and for use in specific concentrations and frequency of
appl ication .
A:Ll pesticides that were on the market prior to the enactment
of FIFIZA were /0grandfathered" under the statute. Therefore, it is
possib:Le that many of these products would not be approved today
under the current pesticide registration procedure. However, EPA
is in the process of reviewing these "existing" pesticides to
4

determine whether any of them should be withdrawn from the market
because of potential harmful effects. The Agency is under
Congressional pressure to move more quickly in its evaluation of
these: grandfathered substances.
The burden of proof as to the "safety" of a new pesticide
rests with the manufacturer submitting the registration
application. If for whatever reason the Agency determines that
the terms of the registration are not being met, EPA may begin the
"Special Review" process for canceling the registration. At this
point, the burden of finding "unreasonable risk" is shifted to the
Agency.
This review is a process, formerly called the Rebuttable
Presumption Against Registration (RPAR), whereby EPA collects and
evaluates information on the pesticide and can request additional
information from the manufacturer to determine whether any uses of
the pesticide 00cause unreasonable adverse effects to human health
or the environment."
Depending on the nature of the new data, the Agency may
propose changes to the terms of the registration under
the
rationale that such changes reduce risks to the level where the
benefits outweigh the risks; or, EPA may proceed with cancellation
by issuing a "Notice of Intent to Cancel" if the Agency finds that
the risks outweigh the benefits. Throughout this entire process,
the palalic has the opportunity to submit comments in an effort to
affect any regulatory action.
5

THE 8K`IEISTIFIC ADVISORY PANEL (SAP)
The S.cientific Advisory Panel (SAP), a standing advisory
committee, was mandated in 1975 by FIFRA to review, for potential
regulatory action, EPA's evaluations of environmental and health
risks posed by specific pesticides.
Regulatory History of Alar
Alar, the Uniroyal Chemical Company trade name for daminozide,
was first registered with the Environmental Protection Agency (EPA)
as a plant growth regulator for potted chrysanthemums in 1963. The
first registered food use was for apples in 1968. To apple
growers, Alar was a major breakthrough; ripe apples stayed on the
tree longer, and remained firmer and redder (better market quality)
during harvest and storage. The tolerance (maximum permissible
residue level) for Alar in apples was set at 30 ppm. From 1968-
1985 Alar was also registered for use on cherries, nectarines,
peaches, pears, grapes, peanuts, tomatoes, and ornamental plants.
However, in 1985 it was estimated that approximately 75% of the
damino.ide in commerce was used on apples; since that time usage
has ds:clined significantly (EPA, 1989).
]:ra the summer of 1984, EPA issued a Notice of Initiation of
a Special Review of pesticide products containing daminozide, which
indicated that the Agency was going to investigate potential
harmful, effects of the pesticide. Of particular concern was a
6

degradation product of daminozide, unsymmetrical dimethylhydrazine
(UDMH). Data from animal studies indicated that both daminozide
and L;rLaNiH elicited "statistically and biologically significant
oncogenic responses at multiple organ sites in multiple species and
straina of animals. UDMH was believed to be a very potent animal
carcinogen and mutagen." (EPA, 1989) Although the database
was limited, the Agency decided to proceed with a cancellation
action
A year later, in the fall of 1985, EPA developed a combined
Prelininary and Final Determination and Draft Cancellation Notice.
The process was accelerated in light of the potentially high
dietary exposure of daminozide and UDMi to children.
The EPA Scientific Advisory Panel (SAP), required under FIFRA
to review this documentation, believed that while the data raised
concerns, they were not sufficient to support a quantitative risk
assessment for either daminozide or UDMH. The Department of
Agricul.ture (USDA) also reviewed the report and argued that EPA had
underestimated the benefits of daminozide use, and therefore,
should reassess its call for cancellation. Although not legally
bound by the SAP decision, the Agency decided to reassess its
position based on the SAP recommendation, and chose not to proceed
with the cancellation action. The Agency did require Uniroyal to
conduct additional testing and collect additional data on the
oncogenic risk of daminozide and UDMH. In the interim, to reduce
exposure, EPA lowered the tolerance for daminozide residues on
apples from 30 ppm to 20 ppm. However, this tolerance was set to
7

expire on July 31, 1987 at which time EPA believed it would have
additional data to evaluate the tolerance further. The Agency also
instructed Uniroyal to include a use advisory with its product
warning not to use the chemical on apples intended for use in apple
sauce and apple juice. (When apples are processed into apple sauce
and juice, the heating process causes daminozide to break down into
UDMH. Therefore, these products have higher concentrations of
UDMH.)
At the time, Jack Moore felt that there was enough evidence
for EPA to be concerned about the carcinogenic potential of
daminozide and its metabolite UDMH, but not enough from a legal
point of view to regulate Alar
under FIFRA. Unlike the
requirements for new pesticides where the registrant must bear the
burden of proof that "the intended use will not present an
unreasonable risk," for currently registered chemicals such as
daminos,ide, the burden of finding "unreasonable risk" lay with EPA.
In 1985-86, when the carcinogenic potential of Alar was made
public:,, consumers acted predictably--they stopped buying apples
until they were assured by their grocers and food processors that
the apples in their stores and products were Alar-free. The
protest was relatively calm, and short-lived.
Civ,er the next several years (1986-88), NRDC, Public Citizen,
and the: States of New York and Maine petitioned and then sued EPA
for noi> amending the tolerance for daminozide residue to zero.
The Ags:ncy claimed it did not have sufficient data to determine
8

whethe:r these residues (20 ppm) posed a health hazard to the U.S.
population. The case was dismissed.
In 1987, the available residue and toxicological data were
not sufficient to determine if a new tolerance would be adequate
to protect public health. Therefore, the 20 ppm tolerance was
extended to January 31, 1989 when new data would be available.
Beginning in 1988, tests by independent laboratories revealed
that claims by one grocery chain of selling Alar-free apples and
products were false. Once again, fear of eating Alar-treated
products caused some consumers to stop buying apples and apple
products.
In early January 1989, EPA staff recommended to Jack Moore to
seek cancellation of all food uses of daminozide. This decision
was based on the new data collected that indicated "that dietary
exposure to UDMH represents a significant carcinogenic risk which
outweighs the benefits of use of daminozide on food crops and
therefore warrants the cancellation of the food uses of daminozide"
(EPA, 1989, p.ii). Agency staff estimated the lifetime risk of
cancer for the general population from dietary exposure to UDMH to
be 4 in 100,000. Infants up to one year are considered the highest
exposure group.
EPA also estimated the benefits derived from the use of
daminozide. The calculations were based on the economic impacts
IU
~
that would result if daminozide were banned. The greatest impact
~
~
would be on the apple industry, as there are "no alternatives to ~
damino2;ide -that alone will accomplish all of the growth regulator A
~
~
~
9 ~

benefits attributed to daminozide" (many of which relate to the
appearance of the fruit). The overall effect on all growers is
estimated to be "an annual income increase of $1.5 million"
resulting from higher market apple prices, with daminozide users
losing $14.5 million and non-users gaining $16.1 million. Growers
of certain apple varieties (particularly Eastern McIntosh and
Stayman), however, may experience annual income losses of $5.7 and
$1.8 million, respectively.
In addition, a cancellation of Alar was estimated to reduce
the supply of fresh apples. "The net social cost (total society
cost) of cancellation of daminozide use on apples based on 10
percent of the crop treated is estimated to range from $18 to $81
million as compared to $44 to $198 million for 1985 usage levels.
Economic impacts of a cancellation for other uses of daminozide,
such as on cherries, grapes, peanuts, and ornamentals, are
predicted to be much less significant. In addition to the apple
industry, peach growers' losses were estimated to range from $1.5
to $5.!5 million (EPA, 1989).
'.rhe Agency staff did not recommend issuing an emergency
suspension of daminozide use on food crops because while the data
did indicate cause for concern, "the level of risk during the time
neces;u.,dry to complete a cancellation action is not unreasonably
high." (EPA, 1989). According to FIFRA, an immediate suspension
is warranted only if EPA determines that the risks present an
immediate hazard. In the interim it was also expected that usage
would decline, thereby lowering the risk of exposure.
10

RI S KASS E S S MEIJT DATA
In historical studies from 1977-78, as well as more recent
data submitted by Uniroyal, daminozide produced vascular and lung
tumors in mice. However, this oncogenic response may be linked to
the presence of UDMH in the test material (possibly by metabolic
conversion). UDMH also produced vascular and lung tumors. On the
other'.lzand, the data from rat studies for both daminozide and UDMH
is less significant. More specific information on these studies
is shown in Table 1.
The estimates of daminozide and UDMH residues in raw and
produced foods are shown in Tables 2 and 3. The estimates of
dietary exposure for the U.S. population as well as for specific
age subsets are shown in Tables 4-9.
T;lae lifetime risk of cancer for the general population due to
dieta:ry exposure to UDMH was estimated to be 4 - 5 x 10-5.
However, because children have a high ratio of food intake for
their bodyweight and because such a high proportion of their diet
comes from;foods that may have high levels of daminozide and/or
UDMH residues, a cancer risk of 5-6 x 10-6 was estimated.
THB NRI)C RElaORT
The NRDC study, "Intolerable Risk: Pesticides in our
Children's Food" examined the levels of pesticide residues found
11

in fruits 'and vegetables to determine whether they presented
health hazard to preschoolers. The NRDC report quantified the
preschooler's dietary exposure to 23 pesticide residues in 27 food
items as well as the resultant potential health risks in terms of
two endpoints--cancer and disruption in central nervous system
functioning.
Tlze principal findings of the study were that
"Preschoolers are being exposed to hazardous levels of
pesticides in fruits and vegetables. Between 5,500 and
6,000 (a risk range of 2.5 x 10 to 2.8 x 10, ) of the
c»rrent population of American preschoolers may
eventually get cancer solely as a result of their
exposure before six years of age to eight pesticides or
metabolites commonly found in fruits and vegetables."
(]qRDC report, p.2)
The report singled out UDNgi as "the greatest source of the cancer
risk identified by NRDC." This risk was estimated as "240 times
greater than the cancer risk considered acceptable by EPA following
a full lifetime of exposure;" one out of 4000 children will get
cancer as a result of ingesting Alar-treated apples.
The report also recommended that Congress amend the current
pesticide regulations to "close loopholes in EPA's and FDA's
regulatory programs." Furthermore, NRDC raised concerns about how
long it takes to lower tolerances or remove hazardous pesticides
from t:he market, and recommended that EPA be granted the authority
to takEe action more quickly. (The Executive Summary of the NRDC
report: is attached.)
12

REGIIIJsTORY ACTION
With his staff's data analyses and recommendations in hand,
the current tolerance on Alar in apples due to expire January 31,
1989, and the findings of the NRDC report soon to be released, Jack
Moore had to make a decision on Alar in addition to deciding
whether or not to be interviewed for 60 Minutes.
STUDY QUESTIONl3
1. Should Jack Moore appear on 60 Minutes? Discuss the pros and
(cions of this decision, taking into account the fact that he
is Acting Administrator of EPA.
2. :L,E he;agrees to the interview, how should Jack Moore prepare
himself?
3. What regulatory decision should the Agency make on Alar?
Should Jack Moore reveal this decision during his 60 Minutes
interview?
4. :Cn addition to "Why hasn't EPA banned Alar?" and "Is the
cairrent law adequate to protect the public from the risks of
pesticides?", what additional questions should Jack Moore
anticipate, and how should he'respond?
5. Vniat f,actors in addition to the "scientific facts" must Jack
rkaore consider in his decision-making concerning Alar?
6. Is the current law adequate to protect the public from the
risks of pesticides?

IML E .1
NEOPLASTIC RESPONSE REPORTED
FOR DAMINOZIDE AND UDMH
IN RODENT CARCINOGENICITY STUDIES
Study Nune Species & Route
DAMINOZII)E
Toth, 19'77 Swiss mouse
(drinking water)
NCI, 19'7l3a B6C3F1 mouse
(dietary)
Tumor Site and Potency (if Calculated)
Blood vessel sarcomas in males and
females; alveolar/bronchiolar adenomas
and carcinomas in males and females;
kidney tumors in males
Liver carcinomas in males; alveolar/
bronchiolar carcinomas and adenomas in
males and females
NCI, 19'713b F344 rat
(dietary)
Uniroya:L, CD-i mouse
1988a (dietary)
UDMH
Toth, 1!3'73 Swiss mouse
, (drinking water)
Toth, 19'77 Hamster
(drinking water)
Haun, 1984 F344 rat
(inhalation)
Haun, 1984 C57BL/6 mouse
(inhalation)
Uniroya7L,, CD-1 mouse
1988e (drinking water)
Uterine endometrial adenocarcinomas and
leiomyosarcomas in females
Dose-related trend with regard to
blood vessel tumors of liver in males
and females; dose-related increase in
alveolar/bronchiolar adenomas in males
and females; no increases in vascular
lung tumors by pairwise comparison
Hemangiomas and hemangiosarcomas of
liver in males and females;
alveolar/bronchiolar adenomas and
carcinomas in males and females; kidney
and liver tumors in males.and females;
Q1 estimated to be 8.9 (mg/kg/day) "
Hemangiomas and hemangiosarsarcomas in I
males; colon tumors in males and females
Pancreatic islet cell adenomas and
*
carcinomas in males; Q
, estimated to be
2.45 (mg/kg/day)'1; pulmonary adenomas ;
and carcinomas in males ~
Hemangiomas and hemangiosarcomas in
females; liver adenomas in females
Blood vessel tumors of the liver in
males and females; Q, estimated to be
0.88 (mg/kg/day)-'; alveolar/bronchiola
adenomas in males and females; Q~
estimated to be 2.9 (mg/kg/day)-
6
ZOZ5546;-M

-~AbL~ 2
ESTIMATES OF DAMINOZIDE LEVELS
'IN RAW AND PRODUCED FOODS
COIyMODITY PERCENT OF
CROP TREATED AVERAGE,
ppm DAMINOZIDE *
Apples 1.00
Apple sauce (-baby ) 0.50
" " (-adul t) 0.40
Ap;ple juice (-baby ) 0.50
" t1 (-adul t) 0.40
Dried raw apples 8.00 #
Dried cooked apple s 4.00 #
Cherries, sweet an d sour 30 23.7
Che:rry filling (an d juice) 1.5
Grapes 0.0
Grape j uice 0.02
Grape preserves 0.02
Nectarines 3 14.5
Peaches 3 11.3
Peaches, canned 11.3
Pearkuts 0.80
Peanut butter 0. 8 0-
Pea r.iut oil 0.80
Pea.rs 3 8.8
Pears, canned 8.8
Beef meat 0.01
" kidney 0.2
11 fat 0.01
" milk 0..01
Poultry teat 0.001
" eggs 0.002
Tomatoes, whole 10 0.20
Tomato j tiice 10 0.30 #
Tomato puree 10 0.66 #
Tomato paste 10 1.10 #
Cat;'iip 10 0.50 #
* For commodity items beef, beef byproducts, milk, poultry and
eggs, the residue values were extrapolated from feeding
studies.
# Residue levels for dried apples includes a concentration
factor of 8. For processed tomato products, the average
residue of 0.2 ppm was multiplied by the following
concentration factors to derive the value used in
calculating exposure: 1.5 for tomato juice, 3.3 for tomato
puree, 5.4 for tomato paste, and 2.5 for catsup.

-fAdLE 3 .
ESTIMATES OF UDMH LEVELS
IN RAW AND PRODUCED FOODS
COMMODITY PERCENT OF
CROP TREATED AVERAGE,
ppb UDMFi *
Apples 2.6
Apple saLtdce (-baby) 33.3
n gu
(-adult)
14
0
Apple juice (-baby) .
44.0
of m (-adult) 23.9
Dried raNr apples 20.8 #
Dried cooked apples 352.0 #
Cherries, sweet and sour 30 18.6
Cherry filling (and juice) 108.1
Grapes 0.0
Grape juice 1.5
Grape preserves 1.5
Nectarines 3 25.0
Peaches 3 21.3
Peaches, canned 21.3
Peanuts 24.9
Peanut butter 24.9
Peanut oil 24.9
Pears 3 11.9
Pears, canned 11.9
Beef ineat: 2.0
" kic[ney 2.0
" fat: 2.0
m
mi].1+e
2.0
Poultry meat 0.5
ir egCfs> 0.5
Tomatoes, whole 10 1.6
Tomato juice 10 2.4 #
Tomato puree 10 5.3 #
Tomato paste 10 . 8.6 #
Catsup 10 4.0 .#
*
For beef, beef byproducts, milk, poultry and eggs, the
residue values were extrapolated from feeding studies.
Residue levels for dried apples includes a concentration
factor of 8. For processed tomato products, the average
residue of 1.6 ppb was multiplied by the following
conc:entration factors to derive the value used in estimating
exposure: 1.5*for tomato juice, 3.3 for tomato puree, 5.4
for tomaio paste; and 2.5 for catsup.

TAbt-E.4
ESTIMATES OF DAMINOZIDE DIETARY EXPOSURE
FOR THE U.S. POPULATION *
OMMODI'C!t AVERAGE
DAILY
CONSUMPTION
(a food/ka bwt/day) RESIDUE
LEVELS
(in ppm EXPOSURE
or ma/ka)(ma dam./ka/day)
Apples, fresh 0.3074 1.00 0.000307
Apples, cooked:
fresh and jui ce 0.2004 0.50 0.001000
Dried raw apples 0.0001 8.00 0.000001 #
Dried cooked apple s 0.0001 4.00 0.0000004 #
Apple juice, raw 0.1709 0.50 0.000085
Cherries, raw fres
and raw 3uice h
0.0105
7.11
0.000075
Cherries, cooked:
fresh and ju
ice 0.0251
1.50
0.000038
Eggs 0.5803 0.002 0.000001
Grapes 0.0438 0.02 0.000001
Grape juice 0.0901 0.02 0.000002
Wine andl sherry 0.0842 0.02 0.000002
Nectarines 0.0130 0.45 0.000006
Peaches. 0.2154 0.34 0.000073
Peanuts, raw,
cooked, and oil 0.0748 0.80 .0.000060
Pears 0.1225 0.26 0.000032
Meat 2.2318 0.20 0.000446
Milk 1.3705 0.01 0.000014
Tomatoes, whole 0.4920 0.20 0.000098
Tomato juice 0.0551 0.30 0.000017 #
Tomato puree 0.1702 0.66 0.000112 #
Tomato paste 0.0395 1.10 0.000043 #
Catsup 0.0420 0.50 0.000021 #
TOTAL 0.000951
or
9.5 x 10'4
mg/kg/day +
For commodity items meat, milk, and eggs, the residue values were
extrapolated from feeding studies data.
Residue levels for dried apples includes a concentration factor of 8.
For processed tomato products, average residue of 0.2 ppm was
multiplied by the following concentration factors: 1.5 for tomato
juica, 3.3 for tomato puree, 5.4 for tomato paste, and 2.5 for catsup.
1 p~a~?-cent of exposure (0.95 x 10~5 mg/kg/day) used to estimate UDMH
contribution from metabolic conversion of daminozide to UDMH when
estimating risk in Table 16.

ESTIMATES OF UDMH DIETARY EXPOSURE
FOR THE U.S. POPULATION *
AVERAGE RESIDUE
DAILY LEVELS
CONSUMPTION (in ppb EXPOSURE
oDITY (cx food/kcr bwt/day) or ua/kq) (ua UDMH/kg/day)
les, fre:all 0.3074
les, coo)ced :
fresh and juice 0.2004
ed raw apples 0.0001
ed cooked apples 0.0001
le juice, raw 0.1709
rries, raw fre'sh
and raw juice 0.0105
rerries, cooked:
fresh aind juice 0.0251
s 0.5803
pes 0.0438
pe juice 0.0901
e and sherry 0.0842
ctarines 0.0130
ches , 0.2154
anuts, raw,
cooked and oil 0.0748
ars 0.1225
at 2.2318
k 1.3705
matoes, whole 0.4920
mato juice 0.0551
mato puree 0.1702
~mato paste 0.0395
F !
sup 0.0420
2.6 0.000799
44.0 0.008818
20.8 0.000002 #
352.0 0.000035 #
33.3 0.005691
5.6 0.000059
108.1 0.002713
0.5 0.000290
0.0 0.000000
1.5 0.000135
1.5 0.000126
0.8 0.000010
0.6 0.000129
24.9 0.001863
0.4 0.000049
2.0 0.004464
2.0 0.021068
1.6 0.000787
2.4 0.000132 #
5.3 0.000902 #
8.6 0.000340 #
'4.0 0.000168 #
0.000047
or
4.7 x 10.5 +
mg/kg/day
For commodity items meat, milk, and eggs, the residue values were
extrapo].zated from feeding studies data. All beef, beef byproducts and
poultry were combined under "meat" in this table.
Residue levels for dried apples includes a concentration factor of 8.
For processed tomato products, average residue of 1.6 was multiplied
by the following concentration factors: 1.5 for tomato juice, 3.3 for
, tomato puree, 5.4 for tomato paste, and 2.5 for catsup.
1 percent. of daminozide exposure (0.95 x 10-4 mg/kg/day) added to
total UDMIi dietary-exposure in Table 16 used to estimate 1 percent
conversiein of daminozide in the gut.

6.
-T ~ &-E
TAS ESTIMATES OF AVERAGE DAILY E%FOSDRE
TO DAMINOZIDE FOR SELECTED AGE SUBSETS
Subset
(Age and Other) Exposure
(mg/kg/day)
AVERRWE (U.S. POPULATION) 0.000951
Nursing infants (<1 year old) 0.003396
Non-nursing infants (<1 year old) 0.005427
Child»en (1 - 6 years old) 0.002786
Children (7 - 12 years old) 0.001514
Males (13 ® 19 years old) 0.000730
Females (13 - 19 years, not pregnant
or nursing) 0.000662
Females (13 + years, pregnan t) 0.000692
Females (13 + years, nursing) 0.000824
Females. (20 + years, not pre gnant
. or nursing) 0.000575
Males (20 + years old) 0.000523

-TA~LF- 7
ESTIMATES OF UDMFi DIETARY RISR
FOR THE U.S. POPULATYON . .
(interim Q¢j = 0.88 mg/kg/day)
Commod:Hy Dietary Exposure
Lua/kajday) Dietary
Risk *
Milk
Apples
Red meatv
Cherries
Peanuts
Eggs
Grapes
Poultry
TomatoE.:
Peaches
Pears
Nectarines 0.021068
0.015331
0.004464
0.002772
0.001863
0.000290
0.000261
0.000252
0.000234-0.00234
0.000129
0.000049
0.000010 1.8 x 10'5
1.4 x 10-5
3.9 x 10-6
2.4 x 10'6
1.6 x 10.6
2.5 x 10'T
2.3 x 10~7
2.2 x 10'7
2.1X10,T-2.1X10-6
1.1 x 10,7
4.3 X 10-8
8.8 x 10,9
TOTALS 0.046715 4.1 X 10-'
+[0.009500 estimated metabolic
UDMH from daminozide) 0.84 X 10'5
4.9 X 10'
* Refer, to II.C.3.b. "Uncertainties that Could Overestimate
the Risk (2-3) "*..
iV

The following Table 4 _. presents the average daily
total dietary exposure to daminozide and UDMH, respectively, for
various age groups to demonstrate the differences in dietary
exposure.
TAS ESTIMATES OF AVERAGE DAILY EXPOSURE
TO UDMH FOR SELECTED AGE SUBSETS
Subset
(Age and Other) Exposure
(mg/kg/day)
AVERAGE (U.S. POPULATION) 0.000047
Nursing infants (<1 year old) 0.000229
Non-nur,sing infants (<1 year old) 0.000410
Children (1 - 6 years old) 0.000138
Children (7 - 12 years old) 0.000071
Males (1,3 - 19 years old) 0.000042
Females (13 - 19 years, not pregnant
or nursing)
0.000034
Females (13 + years, pregnant) 0.000027
Females (13 + years, nursing) 0.000037
Females (20 + years, not pregnant
or nursing)
0.000023
Males (20 + years old) 0.000025
W

Table A describes the average incremental risk for
individuals who belong to any of the three subgroups for which
dietary exposure was estimated. Annual risk was calculated by
multiplying the average residue contribution for each subgroup by
the interim cancer potency factor (Q*1 = 0.88 (mg/kg/day)~) and`
then dividing the calculated risk by 70 lifetime years.
ESTIMATES OF RISKS
TO SEhECTED AGE SUBSETS AND THE GENERAL POPULATION
FROM ONE YEAR EXPOSURE TO UDMH
Subse:t.
(Age and Other) Dietary
Exposure
lma/ka/davt Annual
Risk
Nursing infants (<1 year old) 0.000229 2.9 x 10'6
Non-nuirsing infants (<1 year old) 0.000410 5.2 X 10-6
Children (1 - 6. years old) 0.000138 1.7 x 10'6
AVERFAcE hIFETZ2RE RISK TO
THE GENERAL POPULATION FROM
ONE YEAR EXPOSURE
0.000047
5.9 x 10-7
2. Nondietary risks
The exposure estimates discussed in section II.B.2. are used
as a basis for estimating non-dietary carcinogenic risk. The
Agency assumed that the cancer potency.factor for the dermal
route of eatposure is equivalent to that-for the dietary route
(0.88) and that the length of lifetime exposure is 35 years
worke:cE/70 years lived. To calculate non-dietary carcinogenic
risk from exposure to UDMi, the Agency used the following
equation:
)
UDMH risk = UDMH exposure x 35/70 x Q*1(0.88 (mg/kg/day) _1
Based on this calculation, the carcinogenic risks from worker
exposure t® UDMH is tabulated in Table 18.
